Childhood Cancer in Britain: Incidence, Survival, Mortality

Childhood Cancer in Britain: Incidence, Survival, Mortality

Volumn , Issue , 2009, Pages 1-288

  Stiller, Charles A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Brain tumours; Cancer registry; Childhood cancer; Incidence; Leukaemia; Mortality; Survival

Indexed keywords

EID: 84922790550     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Book

References (315)

1. Ablett S, Pinkerton CR, on behalf of the United Kingdom Children's Cancer Study Group (UKCCSG) (2003). Recruiting children into cancer trials - role of the United Kingdom Children's Cancer Study Group (UKCCSG). British Journal of Cancer, 88, 1661-5.
2. Ajiki W, Tsukuma H, Oshima A, Kawa K (1998). Effects of mass screening for neuroblastoma on incidence, mortality, and survival rates in Osaka, Japan. Cancer Causes & Control: CCC, 9, 631-6.
3. Ajiki W, Tsukuma H, Oshima A (2004). Survival rates of childhood cancer patients in Osaka, Japan. Japanese Journal of Clinical Oncology, 34, 50-4.
4. Alexander F (1998). Clustering of childhood acute leukaemia. The EUROCLUS project. Radiation and Environmental Biophysics, 37, 71-4.
5. Alexander FE, Boyle P, Carli PM et al. (1998). Spatial clustering of childhood leukaemia: summary results from the EUROCLUS project. British Journal of Cancer, 77, 818-24.
6. Alexander FE, Boyle P, Carli PM et al. (1999). Population density and childhood leukaemia: Results of the EUROCLUS study. European Journal of Cancer, 35, 439-44.
7. American Cancer Society. (1968). Manual of Tumor Nomenclature and Coding, 1968. American Cancer Society, Inc., Washington, DC.
8. Antonelli A, Miccoli P, Derzhitski VE, Panasiuk G, Solovieva N, Baschieri L (1996). Epidemiologic and clinical evaluation of thyroid cancer in children from the Gomel region (Belarus). World Journal of Surgery, 20, 867-71.
9. Asmar L, Gehan EA, Newton WA et al. (1994). Agreement among and within groups of pathologists in the classification of rhabdomyosarcoma and related childhood sarcomas: Report of an International study of four pathology classifications. Cancer, 74, 2579-88.
10. Atra A, Gerrard M, Hobson R et al. (1998). Improved cure rate in children with B-cell acute lymphoblastic leukaemia (B-ALL) and stage IV B-cell non-Hodgkin's lymphoma (BNHL) - results of the UKCCSG 9003 protocol. British Journal of Cancer, 77, 2281-5.
11. Atra A, Higgs E, Capra M et al. (2002). ChIVPP chemotherapy in children with stage IV Hodgkin's disease: results of the UKCCSG HD 8201 and HD 9201 studies. British Journal of Haematology, 119, 647-51.
12. Atra A, Imeson JD, Hobson R et al. (2000). Improved outcome in children with advancedstage B-cell non-Hodgkin's lymphoma (B-NHL): results of the United Kingdom Children's Cancer Study Group (UKCCSG) 9002 protocol. British Journal of Cancer, 82, 1396-402.
13. Bailey CC, Gnekow A, Wellek S et al. (1995). Prospective randomised trial of chemotherapy given before radiotherapy in childhood medulloblastoma. International Society of Paediatric Oncology (SIOP) and the (German) Society of Paediatric Oncology (GPO): SIOP II. Medical and Pediatric Oncology, 25, 166-78.
14. Barnes E (2005). Caring and curing: paediatric cancer services since 1960. European Journal of Cancer Care, 14, 373-80.
15. Bassin EB, Wypij D, Davis RB, Mittleman MA (2006). Age-specific fluoride exposure in drinking water and osteosarcoma (United States). Cancer Causes & Control: CCC, 17, 421-8.
16. Becroft DMO, Dockerty JD, Berkeley BB et al. (1999). Childhood cancer in New Zealand 1990 to 1993. Pathology, 31, 83-9.
17. Benjamin S, Kroll ME, Cartwright RA et al. (2000). Haematologists' approaches to the management of adolescents and young adults with acute leukaemia. British Journal of Haematology, 111, 1045-50.
18. Bernstein L, Gurney JG (1999). Carcinomas and other malignant epithelial neoplasms. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 139-47.
19. Bernstein L, Linet M, Smith MA, Olshan AF (1999a). Renal tumors. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 79-90.
20. Bernstein L, Smith MA, Liu L, Deapen D, Friedman DL (1999b). Germ cell, trophoblastic and other gonadal neoplasms. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, pp. MD, pp. 125-37.
21. Bernstein ML, Leclerc JM, Bunin G et al. (1992). A population-based study of neuroblastoma incidence, survival, and mortality in North America. Journal of Clinical Oncology, 10, 323-9.
22. Biondi A, Cimino G, Pieters R, Pui C-H (2000). Biological and therapeutic aspects of infant leukemia. Blood, 96, 24-33.
23. Birch JM (1988). United Kingdom - Manchester Children's Tumour Registry 1954-1970 and 1971-1983. In: Parkin DM et al. (eds.) International Incidence of Childhood Cancer, IARC, Lyon, pp. 299-304.
24. Birch JM, Marsden HB (1987). A classification scheme for childhood cancer. International Journal of Cancer, 40, 620-4.
25. Bithell JF, Draper GJ (1999). Uranium-235 and childhood leukaemia around Greenham Common airfield. Journal of Radiological Protection, 19, 253-9.
26. Bithell JF, Dutton SJ, Draper GJ, Neary NM (1994). The distribution of childhood leukaemias and non-Hodgkin lymphomas near nuclear installations in England and Wales. British Medical Journal, 309, 501-5.
27. Black WC (1998). Increasing incidence of childhood primary malignant brain tumors -enigma or no-brainer?. Journal of the National Cancer Institute, 90, 1249-51.
28. Boque A, Wilson RG (1977). Chronic myeloid leukaemia of adult type in 5-month-old infant. Br Med J, 2, 1397.
29. Bramwell VHC, Burgers M, Sneath R et al. (1992). A comparison of two short intensive adjuvant chemotherapy regimens in operable osteosarcoma of limbs in children and young adults: The first study of the European Osteosarcoma Intergroup. Journal of Clinical Oncology, 10, 1579-91.
30. Brennan BMD, Foot ABM, Stiller C et al. (2004). Where to next with extracranial rhabdoid tumours in children. European Journal of Cancer, 40, 624-6.
31. Breslow N, Beckwith JB, Ciol M, Sharples K (1988). Age distribution of Wilms' tumor: report from the National Wilms' Tumor Study. Cancer Research, 48, 1653-7.
32. Breslow N, McCann B (1971). Statistical estimation of prognosis for children with neuroblastoma. Cancer Research, 31, 2098-103.
33. Buckley JD, Buckley CM, Breslow NE, Draper GJ, Roberson PK, Mack TM (1996). Concordance for childhood cancer in twins. Medical and Pediatric Oncology, 26, 223-9.
34. Bulterys M, Goodman MT, Smith MA, Buckley JD (1999). Hepatic tumors. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 91-7.
35. Bunin GR, Surawicz TS, Witman PA, Preston-Martin S, Davis F, Bruner JM (1998). The descriptive epidemiology of craniopharyngioma. Journal of Neurosurgery, 89, 547-51.
36. Burke GAA, Imeson J, Hobson R, Gerrard M (2003). Localized non-Hodgkin's lymphoma with B-cell histology: cure without cyclophosphamide? A report of the United Kingdom Children's Cancer Study Group on studies NHL 8501 and NHL 9001 (1985-1996). British Journal of Haematology, 121, 586-91.
37. Burkhardt B, Zimmermann M, Oschlies I et al. (2005). The impact of age and gender on biology, clinical features and treatment outcome of non-Hodgkin lymphoma in childhood and adolescence. British Journal of Haematology, 131, 39-49.
38. Campbell J, Wallace WHB, Bhatti LA, Stockton DL, Rapson T, Brewster DH (eds.) (2004). Childhood Cancer in Scotland: trends in incidence, mortality, and survival 1975-1999. Information & Statistics Division, Edinburgh.
39. Capocaccia R, Gatta G, Magnani C, Stiller C, Coebergh J-W, (eds.) (2001). Childhood cancer survival in Europe 1978-1992: the EUROCARE study (special issue). European Journal of Cancer, 37, 671-816.
40. Carli M, Colombatti R, Oberlin O et al. (2004). European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors. Journal of Clinical Oncology, 22, 4787-94.
41. Cartwright RA, Gurney KA, Moorman AV (2002). Sex ratios and the risks of haematological malignancies. British Journal of Haematology, 118, 1071-7.
42. CBTRUS (2002). Statistical report: Primary brain tumors in the United States, 1995-1999. Central Brain Tumor Registry of the United States.
43. Chang M-H, Chen C-J, Lai M-S et al. (1997). Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. New England Journal of Medicine, 336, 1855-9.
44. Chessells JM (1992). Chronic myeloid leukaemia, myeloproliferative disorders, and myelodysplasia. In: Lilleyman JS, Hann IM (eds.) Paediatric Haematology, Churchill Livingstone, pp. 59-63.
45. Chessells JM, Eden OB, Bailey CC, Lilleyman JS, Richards SM (1994). Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia. Leukemia, 8, 1275-9.
46. Chessells JM, Harrison CJ, Kempski H et al. (2002a). Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party. Leukemia, 16, 776-84.
47. Chessells JM, Harrison CJ, Watson SL, Vora AJ, Richards SM (2002b). Treatment of infants with lymphoblastic leukaemia: results of the UK infant protocols 1987-1999. British Journal of Haematology, 117, 306-14.
48. Chessells JM, Harrison G, Richards SM et al. (2002c). Failure of a new protocol to improve treatment results in paediatric lymphoblastic leukaemia: lessons from the UK Medical Research Council trials UKALL X and UKALL XI. British Journal of Haematology, 118, 445-55.
49. Chessells JM, Sieff CA, Rankin A (1983). Acute myeloid leukaemia in childhood: treatment in the United Kingdom. Haematology and Blood Transfusion, 28, 51-5.
50. Clavel J, Goubin A, Auclerc MF et al. (2004). Incidence of childhood leukaemia and non-Hodgkin's lymphoma in France: National Registry of Childhood Leukaemia and Lymphoma, 1990-1999. European Journal of Cancer Prevention, 13, 97-103.
51. Clavel J, Steliarova-Foucher E, Berger C, Danon S, Valerianova Z (2006). Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): report from the ACCIS project. European Journal of Cancer, 42, 2037-49.
52. Coebergh J-W, Reedijk AMJ, de Vries E et al. (2006). Leukaemia incidence and survival in children and adolescents in Europe during 1978-1997: report from the ACCIS project. European Journal of Cancer, 42, 2019-36.
53. Cohn SL (1999). Diagnosis and classification of the small round-cell tumors of childhood. Am J Pathol, 155, 11-5.
54. Committee on Medical Aspects of Radiation in the Environment (COMARE) (2005). COMARE 10th report: the incidence of childhood cancer around nuclear installations in Great Britain. Chilton, Didcot, Health Protection Agency.
55. Committee on Medical Aspects of Radiation in the Environment (COMARE) (2006). COMARE 11th report: The distribution of childhood leukaemia and other childhood cancer in Great Britain. Chilton, Didcot, Health Protection Agency.
56. Conter V, Aricò M, Valsecchi MG et al. (2000). Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) acute lymphoblastic leukemia studies, 1982-1995. Leukemia, 14, 2196-204.
57. Conti EMS, Cercato MC, Gatta G, Ramazzotti V, Roscioni S (2001). Childhood melanoma in Europe since 1978: a population-based survival study. European Journal of Cancer, 37, 780-4.
58. Correa P and Chen VW (1995). Endocrine gland cancer. Cancer, 75, 338-52.
59. Cotterill SJ, Ahrens S, Paulussen M et al. (2000a). Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. Journal of Clinical Oncology, 18, 3108-14.
60. Cotterill SJ, Parker L, Malcolm AJ, Reid M, More L, Craft AW (2000b). Incidence and survival for cancer in children and young adults in the north of England, 1968-1995: a report from the Northern Region Young Persons' Malignant Disease Registry. British Journal of Cancer, 83, 397-403.
61. Cotterill SJ, Pearson ADJ, Pritchard J et al. (2000c). Clinical prognostic factors in 1277 patients with neuroblastoma: results of the European Neuroblastoma Study Group 'survey' 1982-1992. European Journal of Cancer, 36, 901-8.
62. Court Brown WM, Doll R, Bradford Hill A (1960). Incidence of leukaemia after exposure to diagnostic radiation in utero. British Medical Journal, 5212, 1539-45.
63. Craft A, Cotterill S, Malcolm A et al. (1998). Ifosfamide-containing chemotherapy in Ewing's sarcoma: The second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's tumor study. Journal of Clinical Oncology, 16, 3628-33.
64. Darbari A, Sabin KM, Shapiro CN, Schwarz KB (2003). Epidemiology of primary hepatic malignancies in U.S. children. Hepatology, 38, 560-6.
65. Daugaard S (2004). Current soft-tissue sarcoma classifications. European Journal of Cancer, 40, 543-8.
66. de Vries E, Steliarova-Foucher E, Spatz A, Eggermont AMM, Coebergh JWW (2006). Skin cancer incidence and survival in European children and adolescents (1978-1997): report from the ACCIS project. European Journal of Cancer, 42, 2170-82.
67. Desandes E, Clavel J, Berger C et al. (2004). Cancer incidence among children in France, 1990-1999. Pediatric Blood & Cancer, 43, 749-57.
68. Dockerty JD, Becroft DMO, Lewis ME, Williams SM (1997). The accuracy and completeness of childhood cancer registration in New Zealand. Cancer Causes & Control: CCC, 8, 857-64.
69. Dockerty JD, Draper GJ, Vincent TJ, Rowan SD, Bunch KJ (2001). Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. International Journal of Epidemiology, 30, 1428-37.
70. dos Santos Silva I, Swerdlow AJ (1993). Sex differences in the risks of hormonedependent cancers. American Journal of Epidemiology, 138, 10-28.
71. dos Santos Silva I, Swerdlow AJ, Stiller CA, Reid A (1999). Incidence of testicular germcell malignancies in England and Wales: trends in children compared with adults. International Journal of Cancer, 83, 630-4.
72. Douglas NM, Dockerty JD (2005). Population-based survival of children in New Zealand diagnosed with cancer during 1990-1993. European Journal of Cancer, 41, 1604-9.
73. Douglass CW, Joshipura K (2006). Caution needed in fluoride and osteosarcoma study. Cancer Causes & Control: CCC, 17, 481-2.
74. Doyle P, Bunch KJ, Beral V, Draper GJ (1998). Cancer incidence in children conceived with assisted reproduction technology (research letter). Lancet, 352, 452-3.
75. Draper G, Vincent T, Kroll ME, Swanson J (2005). Childhood cancer in relation to distance from high-voltage power lines in England and Wales: a case-control study. British Medical Journal, 330, 1290-4.
76. Draper GJ, Birch JM, Bithell JF et al. (1982). Childhood cancer in Britain: Incidence, mortality and survival, OPCS Studies on Medical and Population Subjects No. 37, HMSO, London.
77. Draper GJ, Heaf MM, Kinnier Wilson LM (1977). Occurrence of childhood cancers among sibs and estimation of familial risks. Journal of Medical Genetics, 14, 81-90.
78. Draper GJ, Kroll ME, Stiller CA (1994). Childhood Cancer. Cancer Surveys, 19-20, 493-517.
79. Draper GJ, Little MP, Sorahan T et al. (1997a). Cancer in the offspring of radiation workers: a record linkage study. British Medical Journal, 315, 1181-8.
80. Draper GJ, Little MP, Sorahan T et al. (1997b). Cancer in the Offspring of Radiation Workers - a Record Linkage Study, NRPB-R298. NRPB, Didcot.
81. Draper GJ, Sanders BM, Brownbill PA, Hawkins MM (1992). Patterns of risk of hereditary retinoblastoma and applications to genetic counselling. British Journal of Cancer, 66, 211-9.
82. Draper GJ, Sanders BM, Kingston JE (1986). Second primary neoplasms in patients with retinoblastoma. British Journal of Cancer, 53, 661-71.
83. Draper GJ, Sanders BM, Lennox EL, Brownbill PA (1996). Patterns of childhood cancer among siblings. British Journal of Cancer, 74, 152-8.
84. Draper GJ, Stiller CA, O'Connor CM et al. (1991). Draper GJ (ed.) The Geographical Epidemiology of Childhood Leukaemia and Non-Hodgkin Lymphomas in Great Britain, 1966-83, OPCS Studies on Medical and Population Subjects No. 53, OPCS, London.
85. Dreifaldt AC, Carlberg M, Hardell L (2004). Increasing incidence rates of childhood malignant diseases in Sweden during the period 1960-1998. European Journal of Cancer, 40, 1351-60.
86. Eden OB, Hann I, Imeson J, Cotterill S, Gerrard M, Pinkerton CR (1992). Treatment of advanced stage T cell lymphoblastic lymphoma: results of the United Kingdom Children's Cancer Study Group (UKCCSG) protocol 8503. British Journal of Haematology, 82, 310-6.
87. Eden OB, Harrison G, Richards S et al. (2000). Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Leukemia, 14, 2307-20.
88. Eden OB, Lilleyman JS, Richards S, Shaw MP, Peto J (1991). Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (Report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood). British Journal of Haematology, 78, 187-96.
89. Eden OB, Stiller CA, Gerrard MP (1988). Improved survival for childhood acute lymphoblastic leukemia: possible effect of protocol compliance. Pediatric Hematology and Oncology, 5, 83-91.
90. Feltbower RG, Moorman AV, Dovey G, Kinsey SE, McKinney PA (2001). Incidence of childhood acute lymphoblastic leukaemia in Yorkshire, UK (research letter). Lancet, 358, 385-7.
91. Ferlay J, Bray F, Pisani P, Parkin DM (2004). GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide, IARC Cancerbase No. 5, version 2.0. IARC Press, Lyon.
92. Fine SW, Humphrey PA, Dehner LP, Amin MB, Epstein JI (2005). Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the World Health Organization 2004 bladder consensus classification. The Journal of Urology, 174, 1976-80.
93. Foreman NK, Thorne R, Berry PJ, Oakhill A, Mott MG (1994). Childhood malignancies in the southwest region of England, 1976-1985. Medical and Pediatric Oncology, 23, 14-9.
94. Gadner H, Grois N, Aricó M et al. (2001). A randomized trial of treatment for multisystem Langerhans' cell histiocytosis. Journal of Pediatrics, 138, 728-34.
95. Gardiner CM, Reen DJ, O'Meara A (1995). Recognition of unusual presentation of natural killer cell leukemia. American Journal of Hematology, 50, 133-9.
96. Gatta G, Capocaccia R, Coleman MP, Gloeckler Ries LA, Berrino F (2002). Childhood cancer survival in Europe and the United States. Cancer, 95, 1767-72.
97. Gatta G, Capocaccia R, Stiller C et al. (2005). Childhood Cancer Survival Trends in Europe: a EUROCARE Working Group Study. Journal of Clinical Oncology, 23, 3742-51.
98. Gatta G, Corazziari I, Magnani C et al. (2003). Childhood cancer survival in Europe. Annals of Oncology, 14, v119-v127.
99. German Childhood Cancer Registry. (2002). German Childhood Cancer Registry Annual Report 2002 (1980-2001). Kaatsch, P. and Spix, C. Mainz, German Childhood Cancer Registry.
100. Gibson BES, Wheatley K, Hann IM et al. (2005). Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials. Leukemia, 19, 2130-8.
101. Gill M, Murrells T, McCarthy M, Silcocks P (1988). Chemotherapy for the primary treatment of osteosarcoma: population effectiveness over 20 years. Lancet, 1, 689-92.
102. Gonzalez JR, Fernandez E, de Toledo JS et al. (2004). Trends in childhood cancer incidence and mortality in Catalonia, Spain, 1975-1998. European Journal of Cancer Prevention, 13, 47-51.
103. Goodman MT, Gurney JG, Smith MA, Olshan AF (1999). Sympathetic nervous system tumours. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 65-72.
104. Goodwin RG, Holme SA, Roberts DL (2004). Variations in registration of skin cancer in the United Kingdom. Clinical and Experimental Dermatology, 29, 328-30.
105. Goubin A, Auclerc MF, Auvrignon A et al. (2006). Survival in France after childhood acute leukaemia and non-Hodgkin's lymphoma (1990-2000). European Journal of Cancer, 42, 534-41.
106. Gurney JG, Smith MA, Bunin GR (1999a). CNS and miscellaneous intracranial and intraspinal neoplasms. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 51-63.
107. Gurney JG, Smith MA, Ross JA (1999b). Cancer among infants. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 149-56.
108. Gurney JG, Swensen AR, Bulterys M (1999c). Malignant bone tumors. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 99-110.
109. Gurney JG, Wall DA, Jukich PJ, Davis FG (1999d). The contribution of nonmalignant tumors to CNS tumor incidence rates among children in the United States. Cancer Causes & Control: CCC, 10, 101-5.
110. Gurney JG, Young JL, Roffers SD, Smith MA, Bunin GR (1999e). Soft tissue sarcomas. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 111-23.
111. Gustafsson G, Schmiegelow K, Forestier E et al. (2000). Improving outcome through two decades in childhood ALL in the Nordic countries: the impact of high-dose methotrexate in the reduction of CNS irradiation. Leukemia, 14, 2267-75.
112. Hann IM, Eden OB, Barnes J, Pinkerton CR, on behalf of the United Kingdom Children's Cancer Study Group (UKCCSG) (1990). 'MACHO' chemotherapy for stage IV B cell lymphoma and B cell acute lymphoblastic leukaemia of childhood. British Journal of Haematology, 76, 359-64.
113. Hann IM, Richards SM, Eden OB, Hill FGH, on behalf of the Medical Research Council Childhood Leukaemia Working Party (1998). Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Leukemia, 12, 1249-55.
114. Hann IM, Stevens RF, Goldstone AH et al. (1997). Randomized comparison of DAT versus ADE as induction chemotherapy in children and younger adults with acute myeloid leukemia. Results of the Medical Research Council's 10th AML trial (MRC AML10). Blood, 89, 2311-8.
115. Harach HR, Williams ED (1995). Childhood thyroid cancer in England and Wales. British Journal of Cancer, 72, 777-83.
116. Hasle H, Kerndrup G, Jacobsen BB (1995). Childhood myelodysplastic syndrome in Denmark: incidence and predisposing conditions. Leukemia, 9, 1569-72.
117. Hasle H, Wadsworth LD, Massing BG, McBride M, Schultz KR (1999). A populationbased study of childhood myelodysplastic syndrome in British Columbia, Canada. British Journal of Haematology, 106, 1027-32.
118. Hawkins MM (1989). Long-term survival and cure after childhood cancer. Archives of Disease in Childhood, 64, 798-807.
119. Hawkins MM, Draper GJ, Kingston JE (1987). Incidence of second primary tumours among childhood cancer survivors. British Journal of Cancer, 56, 339-47.
120. Hawkins MM, Kingston JE, Kinnier Wilson LM (1990). Late deaths after treatment for childhood cancer. Archives of Disease in Childhood, 65, 1356-63.
121. Hawkins MM, Kinnier Wilson LM, Stovall MA et al. (1992). Epipodophyllotoxins, alkylating agents, and radiation and risk of secondary leukaemia after childhood cancer. British Medical Journal, 304, 951-8.
122. Hawkins MM Smith RA (1989). Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. International Journal of Cancer, 43, 399-402.
123. Hawkins MM, Smith RA, Curtice LJ (1988). Childhood cancer survivors and their offspring studied through a postal survey of general practitioners: preliminary results. Journal of the Royal College of General Practitioners, 38, 102-5.
124. Hawkins MM, Swerdlow AJ (1992). Completeness of cancer and death follow-up obtained through the National Health Service Central Register for England and Wales. British Journal of Cancer, 66, 408-13.
125. Hilden JM, Meerbaum S, Burger P et al. (2004). Central nervous system atypical teratoid/rhabdoid tumor: results of therapy in children enrolled in a registry. Journal of Clinical Oncology, 22, 2877-84.
126. Hjalgrim LL, Rostgaard K, Schmiegelow K et al. (2003). Age- and sex-specific incidence of childhood leukaemia by immunophenotype in the Nordic countries. Journal of the National Cancer Institute, 95, 1539-44.
127. Honjo S, Doran HE, Stiller CA et al. (2003). Neuroblastoma trends in Osaka, Japan, and Great Britain 1970-1994, in relation to screening. International Journal of Cancer, 103, 538-43.
128. Innis MD (1972). Nephroblastoma: possible index cancer of childhood. The Medical Journal of Australia, 1, 18-20.
129. Izarzugaza I, Steliarova-Foucher E, Carmen Martos M, Zivkovic S (2006). Non-Hodgkin lymphomas incidence and survival in European children and adolescents (1978-1997): report from the ACCIS project. European Journal of Cancer, 42, 2050-63.
130. Jemal A, Devesa SS, Fears TR, Fraumeni JF (2000). Retinoblastoma incidence and sunlight exposure. British Journal of Cancer, 82, 1875-8.
131. Jemal A, Murray T, Ward E et al. (2005). Cancer statistics, 2005. CA: A Cancer Journal for Clinicians, 55, 10-30.
132. Jenkinson HC, Hawkins MM, Stiller CA, Winter DL, Marsden HB, Stevens MCG (2004). Long-term population-based risks of second malignant neoplasms after childhood cancer in Britain. British Journal of Cancer, 91, 1905-10.
133. Joshi D, Anderson JR, Paidas C, Breneman J, Parham DM, Crist W (2004). Age is an independent prognostic factor in rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatric Blood & Cancer, 42, 64-73.
134. Kaatsch P, Rickert CH, Kühl J, Schüz J, Michaelis J (2001). Population-based epidemiologic data on brain tumors in German children. Cancer, 92, 3155-64.
135. Kaatsch P, Steliarova-Foucher E, Crocetti E, Magnani C, Spix C, Zambon P (2006). Time trends of cancer incidence in European children (1978-1997): report from the ACCIS project. European Journal of Cancer, 42, 1961-71.
136. Kardos G, Baumann I, Passmore SJ et al. (2003). Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7. Blood, 102, 1997-2003.
137. Kingston JE, Hawkins MM, Draper GJ, Marsden HB, Kinnier Wilson LM (1987). Patterns of multiple primary tumours in patients treated for cancer during childhood. British Journal of Cancer, 56, 331-8.
138. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN (1996). Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Archives of Ophthalmology, 114, 1339-43.
139. Kinlen LJ, Dickson M, Stiller CA (1995). Childhood leukaemia and non-Hodgkin's lymphoma near large rural construction sites, with a comparison with Sellafield nuclear site. British Medical Journal, 310, 763-8.
140. Kinlen LJ, Hudson CM, Stiller CA (1991). Contacts between adults as evidence for an infective origin of childhood leukaemia: an explanation for the excess near nuclear establishments in West Berkshire?. British Journal of Cancer, 64, 549-54.
141. Kinnier Wilson LM, Draper GJ (1974). Neuroblastoma, its natural history and prognosis: a study of 487 cases. British Medical Journal, 3, 301-7.
142. Knox EG (2005a). Childhood cancers and atmospheric carcinogens. Journal of Epidemiology and Community Health, 59, 101-5.
143. Knox EG (2005b). Oil combustion and childhood cancers. Journal of Epidemiology and Community Health, 59, 755-60.
144. Knox EG (2006). Roads, railways, and childhood cancers. Journal of Epidemiology and Community Health, 60, 136-41.
145. Knudson AG (1971). Mutation and cancer: statistical study of retinoblastoma. Proceedings of National Academy of Sciences USA, 68, 820-3.
146. Kramarova E, Mann JR, Magnani C, Corraziari I, Berrino F (2001). Survival of children with malignant germ cell, trophoblastic and other gonadal tumours in Europe. European Journal of Cancer, 37, 750-9.
147. Kramárová E, Stiller CA (1996). The international classification of childhood cancer. International Journal of Cancer, 68, 759-65.
148. Kroll ME, Draper GJ, Stiller CA, Murphy MFG (2006). Childhood leukemia incidence in Britain, 1974-2000: time trends and possible relation to influenza epidemics. Journal of the National Cancer Institute, 98, 417-20.
149. Kroll ME, Passmore SJ, Stiller CA et al. (2004). Chapter 9: Childhood Cancer - UK. CancerStats Monograph 2004 - cancer incidence, survival and mortality in the UK and EU, Cancer Research UK, 63-72.
150. Kunze U, Waldhoer T, Haidinger G (1997). Childhood cancer mortality in Austria, 1980-1992. European Journal of Epidemiology, 13, 41-4.
151. La Vecchia C, Levi F, Lucchini F, Kaye SB, Boyle P (1991). Hodgkin's disease mortality in Europe. British Journal of Cancer, 64, 723-34.
152. Lawson SE, Harrison G, Richards S et al. (2000). The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the Medical Research Council UKALLR1 study. British Journal of Haematology, 108, 531-43.
153. Leck I, Birch JM, Marsden HB, Steward JK (1976). Methods of classifying and ascertaining children's tumours. British Journal of Cancer, 34, 69-82.
154. Legler JM, Gloeckler Ries LA, Smith MA et al. (1999). Brain and other central nervous system cancers: recent trends in incidence and mortality. Journal of the National Cancer Institute, 91, 1382-90.
155. Leman JA, Evans A, Mooi W, MacKie RM (2005). Outcomes and pathological review of a cohort of children with melanoma. The British Journal of Dermatology, 152, 1321-3.
156. Lennox EL, Stiller CA, Morris Jones PH, Kinnier Wilson LM (1979). Nephroblastoma: treatment during 1970-3 and the effect on survival of inclusion in the first MRC trial. British Medical Journal, 2, 567-9.
157. Levi F, La Vecchia C (1988). Childhood cancer in Switzerland: Mortality from 1951 to 1984. Oncology, 45, 313-7.
158. Levi F, La Vecchia C, Lucchini F, Negri E, Boyle P (1992). Patterns of childhood cancer incidence and mortality in Europe. European Journal of Cancer, 28A, 2028-49.
159. Levi F, La Vecchia C, Negri E, Lucchini F (2001). Childhood cancer mortality in Europe, 1955-1995. European Journal of Cancer, 37, 785-809.
160. Levi F, Lucchini F, Negri E, Barbui T, La Vecchia C (2000). Trends in mortality from leukemia in subsequent age groups. Leukemia, 14, 1980-5.
161. Levitt G, Bunch KJ, Rogers CA, Whitehead B (1996). Cardiac transplantation in childhood cancer survivors in Britain. European Journal of Cancer, 32A, 826-30.
162. Lie SO, Abrahamsson J, Clausen N et al. (2005). Long-term results in children with AML: NOPHO-AML Study Group - report of three consecutive trials. Leukemia, 19, 2090-100.
163. Lie SO, Jonmundsson G, Mellander L et al. (1996). A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: best outcome in girls, infants, and children with Down's syndrome. British Journal of Haematology, 94, 82-8.
164. Lightfoot T, Bunch K, Ansell P, Murphy M (2005). Ovulation induction, assisted conception and childhood cancer. European Journal of Cancer, 41, 715-24.
165. Linet MS, Ries LAG, Smith MA, Tarone RE, Devesa SS (1999). Recent trends in childhood cancer incidence and mortality in the United States. Journal of the National Cancer Institute, 91, 1051-8.
166. Little MP, Muirhead CR, Stiller CA (1996). Modelling lymphocytic leukaemia incidence in England and Wales using generalisations of the two-mutation model of carcinogenesis of Moolgavkar, Venzon and Knudson. Statistics in Medicine, 15, 1003-22.
167. Lones MA, Auperin A, Raphael M et al. (2000). Mature B-cell lymphoma/leukemia in children and adolescents: intergroup pathologist consensus with the revised European-American Lymphoma Classification. Annals of Oncology, 11, 47-51.
168. Lyons RA, Monaghan SP, Heaven M, Littlepage BNC, Vincent TJ, Draper GJ (1995). Incidence of leukaemia and lymphoma in young people in the vicinity of the petrochemical plant at Baglan Bay, South Wales, 1974-1991. Occupational and Environmental Medicine, 52, 225-8.
169. MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE (2006). Retinoblastoma incidence and survival in European children (1978-1997): report from the ACCIS project. European Journal of Cancer, 42, 2092-102.
170. Madreperla SA, Hungerford JL, Doughty D, Plowman PN, Kingston JE, Singh AD (1998). Treatment of retinoblastoma vitreous base seeding. Ophthalmology, 105, 120-4.
171. Magnani C, Pastore G, Coebergh JWW, Viscomi S, Spix C, Steliarova-Foucher E (2006). Trends in survival after childhood cancer in Europe, 1978-97: report from the ACCIS project. European Journal of Cancer, 42, 1981-2005.
172. Makepeace AR, MacLennan KA, Vaughan Hudson G, Jelliffe AM (1987). Hodgkin's disease in childhood: the British National Lymphoma Investigation experience (BNLI Report No 27). Clinical Radiology, 38, 7-11.
173. Malec E, Lagerlof B (1977). Malignant melanoma of the skin in children registered in the Swedish cancer registry during 1959-1971. Scandinavian Journal of Plastic and Reconstructive Surgery, 11, 125-9.
174. Mann JR, Kasthuri N, Raafat F et al. (1990). Malignant hepatic tumours in children: incidence, clinical features and aetiology. Paediatric and Perinatal Epidemiology, 4, 276-89.
175. Mann JR, Pearson D, Barrett A, Raafat F, Barnes JM, Wallendszus KR (1989). Results of the United Kingdom Children's Cancer Study Group's malignant germ cell tumor studies. Cancer, 63, 1657-67.
176. Martos MC, Olsen JH (1993). Childhood cancer mortality in the European Community, 1950-1989. European Journal of Cancer, 29A, 1783-9.
177. Maurer HM, Gehan EA, Beltangady M et al. (1993). The Intergroup Rhabdomyosarcoma Study-II. Cancer, 71, 1904-22.
178. McKinney PA, Parslow RC, Lane SA et al. (1998). Epidemiology of childhood brain tumours in Yorkshire, UK, 1974-95: geographical distribution and changing patterns of occurrence. British Journal of Cancer, 78, 974-9.
179. McNally RJQ, Alexander FE, Bithell JF (2006). Space-time clustering of childhood cancer in Great Britain: a national study, 1969-1993. International Journal of Cancer, 118, 2840-6.
180. McNally RJQ, Birch JM, Taylor GM, Eden OB (2000). Incidence of childhood precursor Bcell acute lymphoblastic leukaemia in north-west England. Lancet, 356, 485-6.
181. McNally RJQ, Cairns DP, Eden OB, Kelsey AM, Taylor GM, Birch JM (2001a). Examination of temporal trends in the incidence of childhood leukaemias and lymphomas provides aetiological clues. Leukemia, 15, 1612-8.
182. McNally RJQ, Kelsey AM, Cairns DP, Taylor GM, Eden OB, Birch JM (2001b). Temporal increases in the incidence of childhood solid tumors seen in Northwest England (1954-1998) are likely to be real. Cancer, 92, 1967-76.
183. McNally RJQ, Roman E, Cartwright RA (1999). Leukemias and lymphomas: time trends in the UK, 1984-93. Cancer Causes & Control: CCC, 10, 35-42.
184. McNally RJQ, Rowland D, Roman E, Cartwright RA (1997). Age and sex distributions of hematological malignancies in the UK. Hematological Oncology, 15, 173-89.
185. McNeil DE, Coté TR, Clegg L, Rorke LB (2002). Incidence and trends in pediatric malignancies medulloblastoma/primitive neuroectodermal tumor: a SEER update. Medical and Pediatric Oncology, 39, 190-4.
186. McWhirter WR, Dobson C (1995). Childhood melanoma in Australia. World Journal of Surgery, 19, 334-6.
187. McWhirter WR, Dobson C, Ring I (1996). Childhood cancer incidence in Australia, 1982-1991. International Journal of Cancer, 65, 34-8.
188. McWhirter WR, Stiller CA, Lennox EL (1989). Carcinomas in childhood. A registry-based study of incidence and survival. Cancer, 63, 2242-6.
189. Medical Research Council working party on bone sarcoma (1986). A trial of chemotherapy in patients with osteosarcoma. (A report to the Medical Research Council by their Working Party on Bone Sarcoma). British Journal of Cancer, 53, 513-8.
190. Medical Research Council's working party on embryonal tumours in Childhood (1978). Management of nephroblastoma in childhood. Clinical study of two forms of maintenance chemotherapy. Archives of Disease in Childhood, 53, 112-9.
191. Medical Research Council's working party on leukaemia in childhood (1977). Treatment of acute lymphoblastic leukaemia: effect of variation in length of treatment on duration of remission. Report to the Medical Research Council by the Working Party on Leukaemia in Childhood. British Medical Journal, 2, 495-7.
192. Menu-Branthomme A, Rubino C, Shamsaldin A et al. (2004). Radiation dose, chemotherapy and risk of soft tissue sarcoma after solid tumours during childhood. International Journal of Cancer, 110, 87-93.
193. Mertens AC, Yasui Y, Neglia JP et al. (2001). Late mortality experience in five-year survivors of childhood and adolescent cancer: the Childhood Cancer Survivor Study. Journal of Clinical Oncology, 19, 3163-72.
194. Michalkiewicz E, Sandrini R, Figueiredo B et al. (2004). Clinical and outcome characteristics of children with adrenocortical tumors: a report from the International Pediatric Adrenocortical Tumor Registry. Journal of Clinical Oncology, 22, 838-45.
195. Mitchell C, Morris Jones P, Kelsey A et al. (2000). The treatment of Wilms' tumour: results of the United Kingdom Children's Cancer Study Group (UKCCSG) second Wilms' tumour study. British Journal of Cancer, 83, 602-8.
196. Moll AC, Kuik DJ, Bouter LM et al. (1997). Incidence and survival of retinoblastoma in the Netherlands: a register-based study 1862-1995. British Journal of Ophthalmology, 81, 559-62.
197. Möller TR, Garwicz S, Barlow L et al. (2001). Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries. Journal of Clinical Oncology, 19, 3173-81.
198. Morton LM, Wang SS, Devesa SS, Hartge P, Weisenburger DD, Linet MS (2006). Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001. Blood, 107, 265-76.
199. Mott MG, Chessells JM, Willoughby MLN et al. (1984a). Adjuvant low-dose radiation in childhood T cell leukaemia/lymphoma. (Report from the United Kingdom Children's Cancer Study Group -UKCCSG). British Journal of Cancer, 50, 457-62.
200. Mott MG, Eden OB, Palmer MK (1984b). Adjuvant low-dose radiation in childhood non-Hodgkin's lymphoma. (Report from the United Kingdom Children's Cancer Study Group - UKCCSG). British Journal of Cancer, 50, 463-9.
201. Mott MG, Mann JR, Stiller CA (1997). The United Kingdom Children's Cancer Study Group - the first 20 years of growth and development. European Journal of Cancer, 33, 1448-52.
202. Mueller BU (1999). Cancers in children infected with the human immunodeficiency virus. The Oncologist, 4, 309-17.
203. Murphy MFG, Whiteman D, Hey K et al. (2001). Childhood cancer incidence in a cohort of twin babies. British Journal of Cancer, 84, 1460-2.
204. Narod SA, Hawkins MM, Robertson CM, Stiller CA (1997). Congenital anomalies and childhood cancer in Great Britain. American Journal of Human Genetics, 60, 474-85.
205. Neale RE, Mineau G, Whiteman DC, Brownbill PA, Murphy MFG (2005). Childhood and adult cancer in twins: evidence from the Utah genealogy. Cancer Epidemiology Biomarkers and Prevention, 14, 1236-40.
206. Netherlands Cancer Registry (2000). Childhood cancer in the Netherlands 1989-1997. Coebergh JWW, van Dijk JAAM, Janssen-Heijnen MLG, Visser O, Association of Comprehensive Cancer Centres, Utrecht, Netherlands.
207. Newnham A, Møller H (2002). Trends in the incidence of cutaneous malignant melanomas in the south east of England, 1960-1998. J Public Health Med, 24, 268-75.
208. Niemeyer CM, Aricó M, Basso G et al. (1997). Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. Blood, 89, 3534-43.
209. Owen PJ, Miles DPB, Draper GJ, Vincent TJ (2002). Retrospective study of mortality after a water pollution incident at Lowermoor in north Cornwall. British Medical Journal, 324, 1189.
210. Parkes SE, Muir KR, Al Sheyyab M et al. (1993). Carcinoid tumours of the appendix in children 1957-1986: incidence, treatment and outcome. British Journal of Surgery, 80, 502-4.
211. Parkes SE, Muir KR, Camerson AH et al. (1997). The need for specialist review of pathology in paediatric cancer. British Journal of Cancer, 75, 1156-9.
212. Parkin DM, Cardis E, Masuyer E et al. (1993). Childhood leukaemia following the Chernobyl accident: The European Childhood Leukaemia-Lymphoma Incidence Study (ECLIS). European Journal of Cancer, 29A, 87-95.
213. Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB (eds.) (2002) Cancer Incidence in Five Continents Volume VIII, IARC Scientific Publications No. 155, IARC, Lyon.
214. Parkin DM, Kramárová E, Draper GJ, Masuyer E, Michaelis J, Neglia J, Qureshi S, Stiller CA (eds.) (1998) International Incidence of Childhood Cancer: Volume 2, IARC, Lyon.
215. Parkin DM, Stiller CA, Draper GJ, Bieber CA (1988a). The international incidence of childhood cancer. International Journal of Cancer, 42, 511-20.
216. Parkin DM, Stiller CA, Draper GJ, Bieber CA, Terracini B, Young JL (eds.) (1988b). International Incidence of Childhood Cancer (IARC Scientific Publications No. 87). International Agency for Research on Cancer, Lyon.
217. Partoft S, Østerlind A, Hou-Jensen K, Drzewiecki KT (1989). Malignant melanoma of the skin in children (0 to 14 years of age) in Denmark, 1943-1982. Scandinavian Journal of Plastic and Reconstructive Surgery, 23, 55-8.
218. Passmore SJ, Chessells JM, Kempski H, Hann IM, Brownbill PA, Stiller CA (2003). Paediatric myelodys-plastic syndromes and juvenile myelomonocytic leukaemia in the UK: a population-based study of incidence and survival. British Journal of Haematology, 121, 758-67.
219. Passmore SJ, Draper GJ, Brownbill PA, Kroll ME (1998a). Case-control studies of relation between childhood cancer and neonatal vitamin K administration. British Medical Journal, 316, 178-84.
220. Passmore SJ, Draper GJ, Brownbill PA, Kroll ME (1998b). Ecological studies of relation between hospital policies on neonatal vitamin K administration and subsequent occurrence of childhood cancer. British Medical Journal, 316, 184-9.
221. Pastore G, Peris-Bonet R, Carli M, Martíinez-García C, Sánchez de Toledo J, Steliarova-Foucher E (2006a). Childhood soft tissue sarcomas. Incidence and survival in European children (1978-97): report from ACCIS project. European Journal of Cancer, 42, 2136-49.
222. Pastore G, Znaor A, Spreafico F, Graf N, Pritchard-Jones K, Steliarova-Foucher E (2006b). Malignant renal tumours incidence and survival in European children (1978-1997): report from the ACCIS project. European Journal of Cancer, 42, 2103-14.
223. Pearce MS, Parker L, Cotterill SJ, Gordon PM, Craft AW (2003). Skin cancer in children and young adults: 28 years' experience from the Northern Region Young Person's Malignant Disease Registry, UK. Melanoma Res, 13, 421-6.
224. Pearce MS, Parker L, Windebank KP, Cotterill SJ, Craft AW (2005). Cancer in adolescents and young adults aged 15-24 years: a report from the North of England Young Person's Malignant Disease Registry, UK. Pediatric Blood & Cancer, 45, 687-93.
225. Pearson ADJ, Pinkerton CR, Lewis IJ (1994). European Neuroblastoma Group Fifth Study (ENSG 5). A randomised study of dose intensity in stage 4 neuroblastoma over the age of one. In: Evans AE, Biedler JL, Brodeur GM, D'Angio GJ, Nakagawara A (eds.) Progress in Clinical and Biological Research - Advances in Neuroblastoma Research, Wiley-Liss, New York, 385-94.
226. Percy CL, Smith MA, Linet M, Gloeckler Ries LA, Friedman DL (1999). Lymphomas and reticuloen-dothelial neoplasms. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 35-49.
227. Peris-Bonet R, Martínez-García C, Lacour B et al. (2006). Childhood central nervous system tumours. Incidence and survival in Europe (1978-1997): report from the ACCIS project. European Journal of Cancer, 42, 2064-80.
228. Perkins JL, Liu Y, Mitby PA et al. (2005). Nonmelanoma skin cancer in survivors of childhood and adolescent cancer: a report from the childhood cancer survivor study. Journal of Clinical Oncology, 23, 3733-41.
229. Peto R, Pike MC, Armitage P et al. (1977). Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. British Journal of Cancer, 35, 1-39.
230. Pinkerton CR, Hann I, Eden OB et al. (1991). Outcome in stage III non-Hodgkin's lymphoma in children (UKCCSG study NHL 86) - How much treatment is needed?. British Journal of Cancer, 64, 583-7.
231. Pizer BL, Weston CL, Robinson KJ et al. (2006). Analysis of patients with supratentorial primitive neuro-ectodermal tumours entered into the SIOP/UKCCSG PNET 3 study. European Journal of Cancer, 42, 1120-8.
232. Powell JE, Esteve J, Mann JR et al. (1998). Neuroblastoma in Europe: differences in the pattern of disease in the UK. Lancet, 352, 682-7.
233. Pritchard J, Brown J, Shafford E et al. (2000). Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach - results of the first prospective study of the International Society of Pediatric Oncology. Journal of Clinical Oncology, 18, 3819-28.
234. Pritchard J, Cotterill SJ, Germond SM, Imeson J, de Kraker J, Jones DR (2005). High-dose Melphalan in the treatment of advanced neuroblastoma: results of a randomised trial (ENSG-1) by the European Neuroblastoma Study Group. Pediatric Blood & Cancer, 44, 348-57.
235. Pritchard J, Imeson J, Barnes J et al. (1995). Results of the United Kingdom Children's Cancer Study Group first Wilms' tumor study. Journal of Clinical Oncology, 13, 124-33.
236. Pritchard J, Stiller CA, Lennox EL (1989). Over-treatment of children with Wilms' tumour outside paediatric oncology centres. British Medical Journal, 299, 835-6.
237. Punyko JA, Mertens AC, Scott Baker K, Ness KK, Robison LL, Gurney JG (2005). Longterm survival probabilities for childhood rhabdomyosarcoma. A population-based evaluation. Cancer, 103, 1475-83.
238. Rao A, Hills RK, Stiller C et al. (2006). Treatment for myeloid leukaemia of Down syndrome: population-based experience in the UK and results from the Medical Research Council AML 10 and AML 12 trials. British Journal of Haematology, 132, 576-83.
239. Richardson S, Monfort C, Green M, Draper GJ, Muirhead C (1995). Spatial variation of natural radiation and childhood leukaemia incidence in Great Britain. Statistics in Medicine, 14, 2487-501.
240. Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds.) (2006) SEER Cancer Statistics Review, 1975-2003. National Cancer Institute, Bethesda, MD.
241. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) (1999) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, National Cancer Institute SEER Program. NIH Pub No 99-4649. Bethesda, MD.
242. Riley LC, Hann IM, Wheatley K, Stevens RF (1999). Treatment-related deaths during induction and first remission of acute myeloid leukaemia in children treated on the Tenth Medical Research Council acute myeloid leukaemia trial (MRC AML10). British Journal of Haematology, 106, 436-44.
243. Robertson CM and Hawkins MM (1995). Childhood cancer and cystic fibrosis (corres). Journal of the National Cancer Institute, 87, 1486-7.
244. Robertson CM, Hawkins MM, Kingston JE (1994). Late deaths and survival after childhood cancer: implications for cure. British Medical Journal, 309, 162-6.
245. Robertson CM, Stiller CA, Kingston JE (1992). Causes of death in children diagnosed with non-Hodgkin's lymphoma between 1974 and 1985. Archives of Disease in Childhood, 67, 1378-83.
246. Robison LL, Green DM, Hudson M et al. (2005). Long-term outcomes of adult survivors of childhood cancer. Results from the Childhood Cancer Survivor Study. Cancer, 104, 2557-64.
247. Robison LL, Mertens AC, Boice JD et al. (2002). Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Medical and Pediatric Oncology, 38, 229-39.
248. Saksela E, Rintala A (1968). Misdiagnosis of prepubertal malignant melanoma. Reclassification of a cancer registry material. Cancer, 22, 1308-14.
249. Sanders BM, Draper GJ, Kingston JE (1988). Retinoblastoma in Great Britain 1969-80: incidence, treatment, and survival. British Journal of Ophthalmology, 72, 576-83.
250. Sankila R, Martos Jiménez MC, Miljus D, Pritchard-Jones K, Steliarova-Foucher E, Stiller C (2006). Geographical comparison of cancer survival in European children (1988-1997): report from the ACCIS project. European Journal of Cancer, 42, 1972-80.
251. Satgé D, Sasco AJ, Carlsen NLT et al. (1998). A lack of neuroblastoma in Down Syndrome: a study from 11 European countries. Cancer Research, 58, 448-52.
252. Schilling FH, Spix C, Berthold F et al. (2002). Neuroblastoma screening at one year of age. New England Journal of Medicine, 346, 1047-53.
253. Schrappe M, Reiter A, Zimmermann M et al. (2000). Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia, 14, 2205-22.
254. Shah A (2005). Childhood leukaemia in Great Britain: trends in incidence, survival and 'cure' (Thesis). Non-Communicable Disease Epidemiology Unit, London School of Hygiene and Tropical Medicine, pp. 1-269.
255. Shankar AG, Ashley S, Radford M, Barrett A, Wright D, Pinkerton CR (1997). Does histology influence outcome in childhood Hodgkin's disease? Results from the United Kingdom Children's Cancer Study Group. Journal of Clinical Oncology, 15, 2622-30.
256. Shapiro NL, Bhattacharyya N (2005). Population-based outcomes for pediatric thyroid carcinoma. Laryngoscope, 115, 337-40.
257. Shibata Y, Yamashita S, Masayakin VB, Panasyuk GD, Nagataki S (2001). 15 years after Chernobyl: new evidence of thyroid cancer. Lancet, 358, 1965-6.
258. Smith MA, Freidlin B, Gloeckler Ries LA, Simon R (1998). Trends in reported incidence of primary malignant brain tumors in children in the United States. Journal of the National Cancer Institute, 90, 1269-77.
259. Smith MA, Gloeckler Ries LA, Gurney JG, Ross JA (1999a). Leukaemia. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 17-34.
260. Smith MA, Gurney JG, Gloeckler Ries LA (1999b). Cancer among adolescents 15-19 years old. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 157-64.
261. Sorahan T, Haylock RGE, Muirhead CR et al. (2003). Cancer in the offspring of radiation workers: an investigation of employment timing and a reanalysis using updated dose information. British Journal of Cancer, 89, 1215-20.
262. Spix C, Pastore G, Sankila R, Stiller CA, Steliarova-Foucher E (2006). Neuroblastoma incidence and survival in European children (1978-1997): report from the ACCIS project. European Journal of Cancer, 42, 2081-91.
263. Stang A, Streller B, Katalinic A et al. (2006). Incidence of skin lymphoma in Germany. Annals of Epidemiology, 16, 214-22.
264. Stansfeld AG, Diebold J, Kapanci Y et al. (1988). Updated Kiel classification for lymphomas (corres.). Lancet, 1, 292-3.
265. Steliarova-Foucher E, Kaatsch P, Lacour B et al. (2006a). Quality, comparability and methods of analysis of data on childhood cancer in Europe (1978-1997): report from the ACCIS project. European Journal of Cancer, 42, 1915-51.
266. Steliarova-Foucher E, Stiller C, Kaatsch P et al. (2004). Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (the ACCIS project): an epidemiological study. Lancet, 364, 2097-105.
267. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW (2005a). Trends in childhood cancer incidence in Europe, 1970-99. Lancet, 365, 2088.
268. Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P (2005b). International classification of childhood cancer, third edition. Cancer, 103, 1457-67.
269. Steliarova-Foucher E, Stiller CA, Pukkala E, Lacour B, Plesko I, Parkin DM (2006b). Thyroid cancer incidence and survival among European children and adolescents (1978-97) project. Report from the ACCIS. European Journal of Cancer, 42, 2150-69.
270. Stevens MCG (2006). The 'Lost Tribe' and the need for a promised land: the challenge of cancer in teenagers and young adults. European Journal of Cancer, 42, 280-1.
271. Stevens MCG, Rey A, Bouvet N et al. (2005). Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology - SIOP Malignant Mesenchymal Tumor 89. Journal of Clinical Oncology, 23, 2618-28.
272. Stevens RF, Hann IM, Wheatley K, Gray RG, on behalf of the MRC Childhood Leukaemia Working Party (1998). Marked improvements in outcome with chemotherapy alone in paediatric acute myeloid leukaemia: results of the United Kingdom Medical Research Council's 10th AML trial. British Journal of Haematology, 101, 130-40.
273. Stewart A, Webb J, Hewitt D (1958). A survey of childhood malignancies. British Medical Journal, 30, 1495-508.
274. Stiller CA (1988). Centralisation of treatment and survival rates for cancer. Archives of Disease in Childhood, 63, 23-30.
275. Stiller CA (1994a). Centralised treatment, entry to trials and survival. British Journal of Cancer, 70, 352-62.
276. Stiller CA (1994b). International variations in the incidence of childhood carcinomas. Cancer Epidemiology Biomarkers and Prevention, 3, 305-10.
277. Stiller CA, Allen MB, Eatock EM (1995). Childhood cancer in Britain; The national registry of childhood tumours and incidence rates 1978-1987. European Journal of Cancer, 31, 2028-34.
278. Stiller CA, Benjamin S, Cartwright RA et al. (1999). Patterns of care and survival for adolescents and young adults with acute leukaemia - a population-based study. British Journal of Cancer, 79, 658-65.
279. Stiller CA, Bielack SS, Jundt G, Steliarova-Foucher E (2006a). Bone tumours in European children and adolescents, 1978-1997. Report from the ACCIS project. European Journal of Cancer, 42, 2124-35.
280. Stiller CA, Boyle PJ (1996). Effect of population mixing and socioeconomic status in England and Wales, 1979-85, on lymphoblastic leukaemia in children. British Medical Journal, 313, 1297-300.
281. Stiller CA, Bunch KJ, Lewis IJ (2000). Ethnic group and survival from childhood cancer: report from the UK Children's Cancer Study Group. British Journal of Cancer, 82, 1339-43.
282. Stiller CA, Chessells JM, Fitchett M (1994). Neurofibromatosis and childhood leukaemia/lymphoma: a population-based UKCCSG study. British Journal of Cancer, 70, 969-72.
283. Stiller CA, Draper GJ (1989). Treatment centre size, entry to trials, and survival in acute lymphoblastic leukaemia. Archives of Disease in Childhood, 64, 657-61.
284. Stiller CA, Eatock EM (1994). Survival from acute non-lymphocytic leukaemia, 1971-88: a population-based study. Archives of Disease in Childhood, 70, 219-23.
285. Stiller CA, Eatock EM (1999). Patterns of care and survival for children with acute lymphoblastic leukaemia diagnosed between 1980-94. Archives of Disease in Childhood, 81, 202-8.
286. Stiller CA, Marcos-Gragera R, Ardanaz et al. (2006b). Geographical patterns of childhood cancer incidence in Europe, 1988-1997: report from the ACCIS project. European Journal of Cancer, 42, 1952-60.
287. Stiller CA, McKinney PA, Bunch KJ, Bailey CC, Lewis IJ (1991a). Childhood cancer and ethnic group in Britain: a United Kingdom Children's Cancer Study Group (UKCCSG) study. British Journal of Cancer, 64, 543-8.
288. Stiller CA, O'Connor CM, Vincent TJ, Draper GJ (1991b). The National Registry of Childhood Tumours and the leukaemia/lymphoma data for 1966-83. In: Draper GJ (ed.) The Geographical Epidemiology of Childhood Leukaemia and Non-Hodgkin Lymphomas in Great Britain, 1966-83, OPCS Studies on Medical and Population Subjects No. 53, HMSO, London, pp. 7-16.
289. Stiller CA, Parkin DM (1990). International variations in the incidence of childhood renal tumours. British Journal of Cancer, 62, 1026-30.
290. Stiller CA, Parkin DM (1996). Geographic and ethnic variations in the incidence of childhood cancer. British Medical Bulletin, 52, 682-703.
291. Stiller CA, Passmore SJ, Kroll ME, Brownbill PA, Wallis JC, Craft AW (2006c). Patterns of care and survival for patients aged under 40 years with bone sarcoma in Britain, 1980-1994. British Journal of Cancer, 94, 22-9.
292. Stiller CA, Pritchard J, Steliarova-Foucher E (2006d). Liver cancer in European children: incidence and survival, 1978-1997. Report from the ACCIS project. European Journal of Cancer, 42, 2115-23.
293. Strouse JJ, Fears TR, Tucker MA, Wayne AS (2005). Pediatric melanoma: risk factor and survival analysis of the Surveillance, Epidemiology and End Results database. Journal of Clinical Oncology, 23, 4735-41.
294. Swiss Childhood Cancer Registry (2005). Swiss Childhood Cancer Registry Annual Report 2004. Kuehni, C. Bern, Switzerland, Swiss Childhood Cancer Registry.
295. Tait DM, Thornton-Jones H, Bloom HJG, Lemerle J, Morris-Jones P (1990). Adjuvant chemotherapy for medulloblastoma: the first multi-centre control trial of the International Society of Paediatric Oncology (SIOP I). European Journal of Cancer, 26, 464-9.
296. Taylor A, Hawkins M, Griffiths A et al. (2004). Long-term follow-up of survivors of childhood cancer in the UK. Pediatric Blood & Cancer, 42, 161-8.
297. Taylor RE, Bailey CC, Robinson K et al. (2003). Results of a randomized study of preradiation chemotherapy versus radiotherapy alone for nonmetastatic medulloblastoma: the International Society of Paediatric Oncology/United Kingdom Children's Cancer Study Group PNET-3 Study. Journal of Clinical Oncology, 21, 1581-91.
298. The Medical Research Council (1986). Improvement in treatment for children with acute lymphoblastic leukaemia The Medical Research Council UKALL Trials, 1972-84. Lancet, 1, 408-11.
299. Tomlinson GE, Breslow NE, Dome J et al. (2005). Rhabdoid tumor of the kidney in the National Wilms' Tumor Study: age at diagnosis as a prognostic factor. Journal of Clinical Oncology, 23, 7641-5.
300. UKCCSG (2002). Ablett S (ed.) Quest for Cure: UK Children's Cancer Study Group - The First 25 Years. Trident Communications Ltd., Leicester.
301. Valery PC, McWhirter W, Sleigh A, Williams G, Bain C (2002). Farm exposures, parental occupation, and risk of Ewing's sarcoma in Australia: a national case-control study. Cancer Causes & Control: CCC, 13, 263-70.
302. Verrill MW, Judson IR, Harmer CL, Fisher C, Thomas JM, Wiltshaw E (1997). Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children?. Journal of Clinical Oncology, 15, 2611-21.
303. Viscomi S, Pastore G, Mosso ML et al. (2003). Population-based analysis of survival after childhood cancer diagnosed during 1970-1998: a report from the Childhood Cancer Registry of Piedmont, Italy. Haematologica, 88, 974-82.
304. Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S (2000). Trends in cancer incidence in Kyadondo county, Uganda, 1960-1997. British Journal of Cancer, 82, 1585-92.
305. Walker DA, Grundy R, Stiller C (2002). Rare Tumours of Childhood. In: Souhami RL, Tannock I, Hohenberger P, Horoit J-C (eds.) Oxford Textbook of Oncology Volume 2, 2nd edn, Oxford University Press, Oxford, pp. 2669-91.
306. Weeks DA, Beckwith JB, Mierau GW, Luckey DW (1989). Rhabdoid tumor of kidney. A report of 111 cases from the National Wilms' Tumor Study Pathology Center. The American Journal of Surgical Pathology, 13, 439-58.
307. Wilkinson JR, Feltbower RG, Lewis IJ, Parslow RC, McKinney PA (2001). Survival from adolescent cancer in Yorkshire, UK. European Journal of Cancer, 37, 903-11.
308. World Health Organisation (2000). Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S (eds.) International Classification of Diseases for Oncology, 3rd Edition. WHO, Geneva.
309. World Health Organization (1976). International Classification of Diseases for Oncology, ICD-O. World Health Organization, Geneva.
310. World Health Organization (1990). Percy C, Van Holten V, Muir C (eds.) International Classification of Diseases for Oncology Second Edition. World Health Organization, Geneva.
311. World Health Organization (2001). Jaffe ES, Harris NL, Stein H, Vardiman JW (eds.) Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. IARC Press, Lyon.
312. Wright D, McKeever P, Carter R (1997). Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group. Journal of Clinical Pathology, 50, 128-34.
313. Young JL and Miller RW (1975). Incidence of malignant tumors in U.S. children. Journal of Pediatrics, 86, 254-8.
314. Young JL, Smith MA, Roffers SD, Liff JM, Bunin GR (1999). Retinoblastoma. In: Gloeckler Ries LA, Smith MA, Gurney JG, Linet M, Tamra T, Young JL, Bunin GR (eds.) Cancer Incidence and Survival among Children and Adolescents: United States SEER Program 1975-1995, NIH Pub No 99-4649, Bethesda, MD, pp. 73-8.
315. Zuccolo L, Pastore G, Maule M et al. (2004). Time trends of childhood cancer mortality rates: A report from the Childhood Cancer Registry of Piedmont, Italy, 1971-1998. Pediatric Blood & Cancer, 43, 796-9.